BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33181900)

  • 1. Economic burden associated with tuberous sclerosis complex in patients with epilepsy.
    Betts KA; Stockl KM; Yin L; Hollenack K; Wang MJ; Yang X
    Epilepsy Behav; 2020 Nov; 112():107494. PubMed ID: 33181900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance data.
    Fagnani F; Laurendeau C; de Zelicourt M; Marshall J
    Epilepsia Open; 2022 Dec; 7(4):633-644. PubMed ID: 36029029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD).
    Shepherd C; Koepp M; Myland M; Patel K; Miglio C; Siva V; Gray E; Neary M
    BMJ Open; 2017 Oct; 7(10):e015236. PubMed ID: 28982809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, healthcare resource use, and mortality in patients with tuberous sclerosis complex: A population-based study on German health insurance data.
    Strzelczyk A; Rosenow F; Zöllner JP; Simon A; Wyatt G; Holland R; Schubert-Bast S
    Seizure; 2021 Oct; 91():287-295. PubMed ID: 34265583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma.
    Song X; Liu Z; Cappell K; Gregory C; Said Q; Prestifilippo J; Charles H; Hulbert J; Bissler J
    J Med Econ; 2017 Apr; 20(4):388-394. PubMed ID: 27998195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses.
    Mehta D; Davis M; Epstein AJ; Wensel B; Grinnell T; Williams GR
    Neurol Ther; 2020 Dec; 9(2):585-598. PubMed ID: 32949379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy treatment patterns among patients with tuberous sclerosis complex.
    Song J; Swallow E; Said Q; Peeples M; Meiselbach M; Signorovitch J; Kohrman M; Korf B; Krueger D; Wong M; Sparagana S
    J Neurol Sci; 2018 Aug; 391():104-108. PubMed ID: 30103955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink.
    Kingswood JC; Crawford P; Johnson SR; Sampson JR; Shepherd C; Demuth D; Erhard C; Nasuti P; Patel K; Myland M; Pinnegar A; Magestro M; Gray E
    J Med Econ; 2016 Nov; 19(11):1087-1098. PubMed ID: 27267148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, mortality and healthcare economic burden of tuberous sclerosis in Hong Kong: a population-based retrospective cohort study (1995-2018).
    Chu WC; Chiang LL; Chan DC; Wong WH; Chan GC
    Orphanet J Rare Dis; 2020 Sep; 15(1):264. PubMed ID: 32988393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD).
    Kingswood JC; Nasuti P; Patel K; Myland M; Siva V; Gray E
    J Med Econ; 2016 Dec; 19(12):1116-1126. PubMed ID: 27310569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs.
    Vekeman F; Magestro M; Karner P; Duh MS; Nichols T; van Waalwijk van Doorn-Khosrovani SB; Zonnenberg BA
    J Med Econ; 2015; 18(12):1060-70. PubMed ID: 26201433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy in tuberous sclerosis patients in Sweden - Healthcare utilization, treatment, morbidity, and mortality using national register data.
    Welin KO; Carlqvist P; Svensson A; Althin R; Eklund E; Rask O
    Seizure; 2017 Dec; 53():4-9. PubMed ID: 29078087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions.
    Arya R; Tenney JR; Horn PS; Greiner HM; Holland KD; Leach JL; Gelfand MJ; Rozhkov L; Fujiwara H; Rose DF; Franz DN; Mangano FT
    J Neurosurg Pediatr; 2015 Jan; 15(1):26-33. PubMed ID: 25360852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study.
    May D; Kponee-Shovein K; Mahendran M; Downes N; Sheng K; Lefebvre P; Cheng WY
    BMC Neurol; 2023 Apr; 23(1):141. PubMed ID: 37016355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
    Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
    Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States.
    Laliberté F; Duh MS; Barghout V; Germain G; Frech F; Plauschinat C; Lejeune D; Malhotra M; Faught E
    Epilepsy Behav; 2021 May; 118():107927. PubMed ID: 33812233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic Drug Titration and Related Health Care Resource Use and Costs.
    Fishman J; Kalilani L; Song Y; Swallow E; Wild I
    J Manag Care Spec Pharm; 2018 Sep; 24(9):929-938. PubMed ID: 29486142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.